Screen LibraryThe opioid epidemic in the United States : missed opportunities and policy failures /
"The current opioid epidemic in the United States began in the mid-1990s with the introduction a new drug, OxyContin, viewed as a safer and more effective opiate for chronic pain management. By 2017, the opioid epidemic had become a full-blown crisis as over 2 million Americans had become depen...
Saved in:
| Main Authors: | |
|---|---|
| Group Author: | |
| Published: |
Routledge, Taylor & Francis Group,
|
| Publisher Address: | New York, NY : |
| Publication Dates: | 2022. |
| Literature type: | Book |
| Language: | English |
| Subjects: | |
| Summary: |
"The current opioid epidemic in the United States began in the mid-1990s with the introduction a new drug, OxyContin, viewed as a safer and more effective opiate for chronic pain management. By 2017, the opioid epidemic had become a full-blown crisis as over 2 million Americans had become dependent on and abused prescription pain pills and street drugs. This book examines the origins, development, and rise of the opioid epidemic in the United States from the perspective of the public policy process. The authors, political scientists Kant Patel and Mark Rushefsky, discuss institutional features of the American political system that impact the making of public policy, arguing that the fragmentation of that system hinders the ability to coherently address policy problems, taking the opioid epidemic as an example. The book begins with a brief historical examination of the history of the problem of opioid addiction and crises in the United States and public policy responses to past crises, but the main focus is on our current national public health emergency. The book analyzes: The origins of the current crisis Indicators and warning signs pointing to the emergence of a significant public problem Factors that contributed to the opioid crisis Why the crisis emerged in the United States and not in other Western countries The nature and scope of the opioid crisis, including socio-economic and demographic characteristics and the human, social, and economic costs Presidential administrations' public response, and non-response, to the opioid crisis - Parallels between the role played by opioid manufacturers and tobacco/cigarette manufacturers in creating the problem of addiction, resulting in high mortality rates, and the public policy response to both. This book explores the national policy response to the opioid crisis, as well as state and local government responses and separation of powers, including how the three branches of government deal with the opioid problem. The authors conclude with a discussion of how accurate problem definition, problem diagnosis, and appropriate and timely responses could have produced a more appropriate and robust policy response--policy process tools that will be essential in fighting both the current crisis and the next one. The Opioid Epidemic in the United States is essential reading for policy analysis courses in political science, health, and social work programs, as well as for US policymakers at the local, state, and national levels"-- |
| Carrier Form: | xiv, 360 pages : illustrations ; 24 cm |
| Bibliography: | Includes bibliographical references and index. |
| ISBN: |
9781032105215 1032105216 9781032105598 1032105593 |
| Index Number: | HV5825 |
| CLC: | R969.3-097.12 |
| Call Number: | R969.3-097.12/P295 |
| Contents: |
The policy process and policy cycles -- The first opiate crisis: 1860s to 1920s -- The second opioid crisis: 1960s to 2000 -- The third opioid crisis: 2000-present -- State governments and the current opioid crisis -- A perfect storm: big pharma, FDA, DEA, and the opioid crisis -- The global context of the opioid crisis -- Opioid epidemics and public policy. |